drugset / Trial / NCT00979368
Safety Study of BMS-816336 in Healthy Male Subjects
RandomizedParallel-groupTriple-blind
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics following single oral doses of BMS-816336 in healthy male subjects.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BMS-816336 | Small molecule | 15 mg | Oral |
| Comparator | BMS-816336 | Small molecule | 60 mg | Oral |
| Comparator | BMS-816336 | Small molecule | 180 mg | Oral |
| Comparator | BMS-816336 | Small molecule | 450 mg | Oral |
| Comparator | BMS-816336 | Small molecule | 900 mg | Oral |